PUBLICATIONS
An efficient, scarless, selection-free technology for phage engineering
Moran G. Goren, Tridib Mahata, Udi Qimron | RNA Biology, in press, 2023
Characterization of antibiotic resistomes by reprogrammed bacteriophage-enabled functional metagenomics in clinical strains
Apjok G, Számel M, Christodoulou C, Seregi V, Vásárhelyi BM, Stirling T, Eszenyi B, Sári T, Vidovics F, Nagrand E, Kovács D, Szili P, Lantos II, Méhi O, Jangir PK, Herczeg R, Gálik B, Urbán P, Gyenesei A, Draskovits G, Nyerges Á, Fekete G, Bodai L, Zsindely N, Dénes B, Yosef I, Qimron U, Papp B, Pál C, Kintses B. | Nature Microbiology, 8(3):410-423, 2023
Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature
A Munitz, L Edry-Botzer, M Itan, R Tur-Kaspa, D Dicker, D Markovitch, M Goren, M Mor, S Lev, T Gottesman, K Muhsen, D Cohen, M Stein, U Qimron, N Freund, Y Wine, M Gerlic | Scientific Reports, 11(1):3461, 2021
A genetic system for biasing the sex ratio in mice
Yosef I, Edry-Botzer L, Globus R, Shlomovitz I, Munitz A, Gerlic M, and Qimron U | EMBO Reports, (8):e48269, 2019
News and Views by David Zarkower and Michael Smanski in EMBO Rep – same issue
SELECTION OF GENETICALLY MODIFIED BACTERIOPHAGES USING THE CRISPR-CAS SYSTEM
Manor M., Qimron U. | Bio Protoc. 2017 Aug 5;7(15). pii: e2431. doi: 10.21769/BioProtoc.2431
A TECHNOLOGICAL AND REGULATORY OUTLOOK ON CRISPR CROP EDITING
Globus R., Qimron U. | J Cell Biochem. 2017 Jul 21
CD300F:IL-5 CROSS-TALK INHIBITS ADIPOSE TISSUE EOSINOPHIL HOMING AND SUBSEQUENT IL-4 PRODUCTION
Rozenberg P., Reichman H., Zab-Bar I., Itan M., Pasmanik-Chor M., Bouffi C., Qimron U., Bachelet I., Fulkerson P.C., Rothenberg M.E., Munitz A. | Sci Rep. 2017 Jul 19;7(1):5922
FULL SHUT-OFF OF ESCHERICHIA COLI RNA-POLYMERASE BY T7 PHAGE REQUIRES A SMALL PHAGE-ENCODED DNA-BINDING PROTEIN
Tabib-Salazar A., Liu B., Shadrin A., Burchell L., Wang Z., Wang Z., Goren M.G., Yosef I., Qimron U., Severinov K., Matthews S.J., Wigneshweraraj S. | Nucleic Acids Res. 2017 Jul 27;45(13):7697-7707
EXTENDING THE HOST RANGE OF BACTERIOPHAGE PARTICLES FOR DNA TRANSDUCTION
Yosef I., Goren M.G., Globus R., Molshanski-Mor S., Qimron U. | Mol Cell. 2017 Jun 1;66(5):721-728.e3. | Cover page – Molecular Cell June 1st 2017
SENSITIZING PATHOGENS TO ANTIBIOTICS USING THE CRISPR-CAS SYSTEM
Goren M., Yosef I., Qimron U. | Drug Resist Updat. 2017 Jan;30:1-6
PHENOTYPIC HETEROGENEITY IN A BACTERIOPHAGE POPULATION ONLY APPEARS AS STRESS-INDUCED MUTAGENESIS
Yosef I., Edgar R., Qimron U. | Curr Genet. 2016 Nov;62(4):771-773
REPEAT SIZE DETERMINATION BY TWO MOLECULAR RULERS IN THE TYPE I-E CRISPR ARRAY
Goren M.G., Doron S., Globus R., Amitai G., Sorek R., Qimron U. | Cell Rep. 2016 Sep 13;16(11):2811-2818
NATURAL SELECTION UNDERLIES APPARENT STRESS-INDUCED MUTAGENESIS IN A BACTERIOPHAGE INFECTION MODEL
Yosef I., Edgar R., Levy A., Amitai G., Sorek R., Munitz A., Qimron U. | Nat Microbiol. 2016 Apr 18;1(6):16047
COUNTERACTING SELECTION FOR ANTIBIOTIC-RESISTANT BACTERIA
Yosef I., Manor M., Qimron U. | Bacteriophage. 2016 Mar 7;6(1):e1096996
ADAPTATION IN CRISPR-CAS SYSTEMS
Sternberg S.H., Richter H., Charpentier E., Qimron U. | Mol Cell. 2016 Mar 17;61(6):797-808
PROGRAMMING BACTERIOPHAGES BY SWAPPING THEIR SPECIFICITY DETERMINANTS
Goren M.G., Yosef I., Qimron U. | Trends Microbiol. 23(12):744-746, 2015
TEMPERATE AND LYTIC BACTERIOPHAGES PROGRAMMED TO SENSITIZE AND KILL ANTIBIOTIC-RESISTANT BACTERIA
Yosef I., Manor M., Kiro R., Qimron U. | Proc Natl Acad Sci USA, 112(23):7267-7272, 2015
SPACER ADAPTATION BIASES EXPLAIN PREFERENCE FOR FOREIGN DNA IN CRISPR ADAPTATION
Levy A.*, Goren M.G.*, Yosef I., Auster O., Manor M., Amitai G., Edgar R., Qimron U.†, #, Sorek R.†, # *contributed equally; †joint supervision of work; #corresponding author | Nature, (article), 520(7548):505-510, 2015 | Highlighted in Nature Reviews Microbiology and in numerous press releases
MICROBIOLOGY NEWS AND VIEWS: HOW BACTERIA GET SPACERS FROM INVADERS
Yosef I. and Qimron U. | Nature, 519(7542):166-167, 2015
USING THE CRISPR/CAS SYSTEM TO POSITIVELY SELECT MUTANTS IN GENES ESSENTIAL FOR ITS FUNCTION
Yosef I., Goren M.G., Edgar R., Qimron U. | Methods in Molecular Biology, 1311:233-250, 2015
REVEALING BACTERIAL TARGETS OF GROWTH INHIBITORS ENCODED BY BACTERIOPHAGE T7
Molshanski-Mor S., Yosef I., Kiro R., Edgar R., Manor M., Gershovits M., Laserson M., Pupko T., Qimron U. | Proc Natl Acad Sci USA, 111(52):18715–18720, 2014
DIFFERENT APPROACHES FOR USING BACTERIOPHAGES AGAINST ANTIBIOTIC-RESISTANT BACTERIA
Yosef I., Kiro R., Molshanski-Mor S., Edgar R., Qimron U. | Bacteriophage, 4(1):e28491, 2014
EFFICIENT ENGINEERING OF A BACTERIOPHAGE GENOME USING THE TYPE I-E CRISPR-CAS SYSTEM
Kiro R., Shitrit D., Qimron U. | RNA Biology, 11(1):42-4, 2014
GENE PRODUCT 0.4 INCREASES BACTERIOPHAGE T7 COMPETITIVENESS BY INHIBITING HOST CELL DIVISION
Kiro R., Molshanski-Mor S., Yosef I., Milam S.L., Erickson H.P., Qimron U. | Proc Natl Acad Sci USA, 110(48):19549-54, 2013. Recommended by F1000
DNA MOTIFS DETERMINING THE EFFICIENCY OF ADAPTATION INTO THE ESCHERICHIA COLI CRISPR ARRAY
Yosef I., Shitrit D., Goren M.G., Burstein D., Pupko T., Qimron U. | Proc Natl Acad Sci USA, 110(35):14396-401, 2013
CRISPR ADAPTATION IN ESCHERICHIA COLI TYPE I-E SYSTEM
Kiro R., Goren M.G., Yosef I., Qimron U. | Biochemical Society Transactions, 41(6):1412-5, 2013
DISCOVERY OF FUNCTIONAL TOXIN/ANTITOXINÂ SYSTEMS IN BACTERIA BY SHOTGUN CLONING
Sberro H.*, Leavitt A.*, Kiro R.*, Koh E., Peleg Y., Qimron U., Sorek R. *contributed equally | Mol Cell, 50(1):136-48, 2013. Recommended by F1000
EXPERIMENTAL DEFINITION OF A CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC DUPLICON IN ESCHERICHIA COLI
Goren M.G., Yosef I., Auster O., Qimron U. | Journal of Molecular Biology, 423(1):14-6, 2012
THE BACTERIAL CRISPR/CAS SYSTEM AS ANALOG OF THE MAMMALIAN ADAPTIVE IMMUNE SYSTEM
Goren M.G., Yosef I., Edgar R., Qimron U. | RNA Biology, 9(5):549-54, 2012
PROTEINS AND DNA ELEMENTS ESSENTIAL FOR THE CRISPR ADAPTATION PROCESS IN ESCHERICHIA COLI
Yosef I., Goren M.G., Qimron U. | Nucleic Acids Research, 40(12):5569-76, 2012. Recommended by F1000
REVERSING BACTERIAL RESISTANCE TO ANTIBIOTICS BY PHAGE-MEDIATED DELIVERY OF DOMINANT SENSITIVE GENES
Edgar R., Friedman N., Molshanski-Mor S., Qimron U. | Applied and Environmental Microbiology, 78(3):744-51, 2012 | Highlighted in Nature Reviews Microbiology (PDF), Nature Medicine (PDF), Wall Street Journal (PDF), and international and local press
HTPG IS ESSENTIAL FOR ACTIVITY OF THE ESCHERICHIA COLI CRISPR/CAS SYSTEM
Yosef I., Goren M. G., Kiro R., Edgar R., Qimron U. | Proc Natl Acad Sci USA, 108(50):20136-41, 2011
E. COLI CRISPR SYSTEM PROTECTS FROM Λ LYSOGENIZATION, LYSOGENS, AND PROPHAGE INDUCTION
Edgar R., Qimron U. | J. Bacteriology, 192(23):6291-4, 2010
OPINION
Thou shalt not cleave DNA-only repress transcription: A compact Cas protein representing a new CRISPR-Cas subtype
Mahata T and Qimron U. | Mol Cell, 82(23):4403-4404, 2022